Community-Acquired Pneumonia Current & Future State
|
|
- Frederick Carter
- 5 years ago
- Views:
Transcription
1 Community-Acquired Pneumonia Current & Future State Brad Sharpe, M.D. Professor of Clinical Medicine Department of Medicine UCSF I have no relevant financial relationships to disclose. 1. In 1898, William Osler described community-acquired pneumonia as: a. An ailment that often leads to suffocation and death. b. A friend of the aged. c. A common and mortal disease which can be diagnosed by simple observation and percussion of the chest. d. Bad. Really bad. 1
2 1. In 1898, William Osler described community-acquired pneumonia as: a. An ailment that often leads to suffocation and death. b. A friend of the aged. c. A common and mortal disease which can be diagnosed by simple observation and percussion of the chest. d. Bad. Really bad. "Pneumonia may well be called the friend of the aged. Taken off by it in an acute, short, not often painful illness, the old man escapes those cold gradations of decay so distressing of himself and to his friends. -- William Osler, M.D.,
3 Brad, pneumonia sucks. -- Mary R. Sharpe November 2011 Update in CAP 3
4 Roadmap Background Etiology Diagnosis Treatment Prevention Specific Goals: Describe the most common causes of community-acquired pneumonia in the outpatient setting Order appropriate diagnostic tests for CAP Initiate appropriate antibiotics in the treatment of community-acquired pneumonia (CAP) State the optimal duration of therapy in CAP State the benefits and need for preventative measures for CAP CAP: Current & Future 4
5 Caveats Will not talk about healthcare-associated pneumonia (HCAP) Will not discuss admission decision (complex) Syllabus or specific questions: Community-Acquired Pneumonia Roadmap Background Etiology Diagnosis Treatment Prevention 5
6 CAP: Background 5 million cases/year in the U.S. 80% of CAP is treated outpatient Sixth leading cause of death Inpatient mortality 10-35% Outpatient mortality < 1% CAP: Background Some evidence that quality of care for African-Americans with CAP is worse Higher mortality among Caucasians Mortensen EM, et al. BMC Health Serv Res. 2004;4:20. Mayr FB, et al. Crit Care Med. 2010;38:759. 6
7 CAP: Background Cough 90%* Dyspnea 66% Sputum 66% Pleuritic chest pain 50% * Yet, only 4% of all visits for cough are pneumonia Halm EA, Teirstein AS. N Engl J Med 2002;347(25):2039. Clinical Presentation: Geriatrics Less classic presentations 10% have NONE of the classic signs or symptoms Up to 35% will not have fever Up to 50% will have altered mental status Up to 50% will have asthenia Mehr DR, et al. J Fam Prac 2001;50(11):1101. Riquelme R, et al. Am J Respir Crit Care Med 1997;156:1908. Sund-Levander M, et al. Scand J Inf Dis. 2003;35:306. Simoneti AF, et al. Ther Adv ID. 2014;2:3. Community-Acquired Pneumonia 7
8 Roadmap Background Etiology Diagnosis Treatment Prevention Typical vs. Atypical Typical organisms S. pneumoniae, H. influenzae, M. catarrhalis, etc. 8
9 Typical vs. Atypical Atypical organisms M. pneumoniae, C. pneumoniae, Legionella spp, etc. Typical vs. Atypical Classic teaching is not supported by the literature Some general trends S. pneumoniae in older pts, co-morbidities Mycoplasma in patients < 50 years old Bilateral hazy opacities more likely to be atypical (but not always) 9
10 Typical vs. Atypical Classic teaching is not supported by the literature Some general trends But - no history, exam, laboratory, or radiographic features predict organism Walking pneumonia Classic lobar pneumonia Etiology of CAP Outpatients (mild) Non-ICU inpatients ICU inpatient File TM. Lancet 2003;362:
11 Microbiology of CAP Jain S, et al. NEJM Community-Acquired Pneumonia Microbiology of CAP Prospective study of 2320 patients with CAP admitted to 5 hospitals All extensive diagnostic evaluation Blood cultures, sputum cultures Urine antigen for S. pneumoniae & Legionella Nasopharyngeal PCR for viruses, Chlamydophila, Mycoplasma Some serologic testing Jain S, et al. NEJM Community-Acquired Pneumonia 11
12 Microbiology of CAP Jain S, et al. NEJM Community-Acquired Pneumonia Microbiology of CAP Jain S, et al. NEJM Community-Acquired Pneumonia 12
13 Microbiology of CAP 1) Rhinovirus 2) Influenza 3) Streptococcus pneumoniae Jain S, et al. NEJM Community-Acquired Pneumonia Microbiology of CAP No pathogen detected in > 60% of patients Real-world ~ 80-90% Many possible explanations Mainly viruses? Inadequate diagnostic testing Jain S, et al. NEJM Community-Acquired Pneumonia 13
14 Etiology of CAP Outpatients (mild) Non-ICU inpatients ICU inpatient File TM. Lancet 2003;362:1991. Etiology of CAP Outpatients (mild) Non-ICU inpatients ICU inpatient Resp. viruses S pneumoniae M pneumoniae C pneumoniae H influenzae Resp. viruses S pneumoniae M pneumoniae C pneumoniae H influenzae Legionella spp S pneumoniae Legionella H influenzae GNRs S aureus Resp. viruses (?) File TM. Lancet 2003;362:1991. Metlay JP, et al. JAMA 1997;278(17):1440. CAP: Current & Future 14
15 Take Home Points 1) 2) 3) 4) 5) Community-Acquired Pneumonia Take Home Points 1) Cover typical and atypical bacteria 2) 3) 4) 5) Community-Acquired Pneumonia 15
16 Roadmap Background Etiology Diagnosis Treatment Prevention 2. A 65-year old man presents to urgent care complaining of subjective fever, chills, and productive cough x 3 days. He reports mild shortness of breath. His temperature is 38.6 o C, RR 20, O 2 saturation 95% on RA. He has crackles at the right base on lung exam. You should: a. Treat for community-acquired pneumonia. b. Send him for a PA and lateral CXR. c. Send him for blood and sputum cultures. d. Prescribe sudafed and robitussin and send him home. e. Perform trans-tracheal aspiration f. B and C 16
17 2. A 65-year old man presents to urgent care complaining of subjective fever, chills, and productive cough x 3 days. He reports mild shortness of breath. His temperature is 38.6 o C, RR 26, O 2 saturation 95% on RA. He has crackles at the right base on lung exam. You should: a. Treat for community-acquired pneumonia. b. Send him for a PA and lateral CXR. c. Send him for blood and sputum cultures. d. Prescribe sudafed and robitussin and send him home. e. Perform trans-tracheal aspiration f. B and C Diagnosis of CAP 1) Select clinical features (e.g. cough, fever, sputum, pleuritic chest pain) AND 2) Infiltrate by CXR or other imaging IDSA/ATS Guidelines. CID. 2007;44:S
18 Chest Radiograph Gold Standard All expert guidelines state should have positive CXR to make diagnosis History & exam not good enough (50% sensitive) In outpt setting, should see an infiltrate. Order CXR if you are concerned about CAP If CXR negative, likely should not treat for CAP In the inpatient setting, can see pneumonia with a negative CXR (~30%) Metlay J. Ann Intern Med Community-Acquired Pneumonia Chest Radiograph Gold Standard? Should (generally) order CXR in all patients with suspected pneumonia. In the hospital, a positive CXR is not necessary to treat as CAP (but consider other diagnoses). Community-Acquired Pneumonia 18
19 2. A 65-year old man presents to urgent care complaining of subjective fever, chills, and productive cough x 3 days. He reports mild shortness of breath. His temperature is 38.6 o C, RR 26, O 2 saturation 95% on RA. He has crackles at the right base on lung exam. You should: a. Treat for community-acquired pneumonia. b. Send him for a PA and lateral CXR. c. Send him for blood and sputum cultures. d. Prescribe sudafed and robitussin and send him home. e. Perform trans-tracheal aspiration f. B and C 2. A 65-year old man presents to urgent care complaining of subjective fever, chills, and productive cough x 3 days. He reports mild shortness of breath. His temperature is 38.6 o C, RR 26, O 2 saturation 95% on RA. He has crackles at the right base on lung exam. You should: a. Treat for community-acquired pneumonia. b. Send him for a PA and lateral CXR. c. Send him for blood and sputum cultures. d. Prescribe sudafed and robitussin and send him home. e. Perform trans-tracheal aspiration f. B and C 19
20 Blood Cultures Specific organism vs. contaminants, cost Reality: No evidence of a benefit Rarely positive = ~ 7% Contaminant rate = ~ 7% More likely to be positive if sicker ICU, septic shock, etc. Community-Acquired Pneumonia Blood Cultures in CAP In general, do not get blood cultures for outpatient CAP For inpatient CAP, blood cultures are optional Consider if risk factors: ICU, severe sepsis, cavitary infiltrates, pleural effusion IDSA/ATS Guidelines. CID. 2007;44:S
21 Sputum for CAP Complicated and controversial Simple, inexpensive, specific for pneumococcus Problems include: Up to 30% could not produce adequate sputum Good quality available in only 14% Most don t narrow antibiotics Sputum Cultures in CAP In general, sputum cultures are not indicated in outpatient CAP For inpatient CAP, sputum is indicated: High-quality specimen, right to the lab ICU, cavitary infiltrates, underlying lung disease IDSA/ATS Guidelines. CID. 2007;44:S
22 The future in CAP - biomarkers Procalcitonin: precursor of calcitonin No hormonal activity Inflammatory marker Increased in bacterial infection Diagnosing Pneumonia Procalcitonin: Bacterial vs. Non-bacterial Intl J. Lung Dz
23 Meta-analysis/systematic review Four studies, ~3500 patients with respiratory tract infections Specific algorithm Less antibiotic exposure A 22% decrease in prescriptions Average 2.3 days less abx overall No difference in mortality/clinical outcomes Soni NJ, et al. JHM. 2013;8:530. Take Home Points 1) Cover typical and atypical bacteria 2) 3) 4) 5) Community-Acquired Pneumonia 23
24 Take Home Points 1) Cover typical and atypical bacteria 2) Get the CXR, skip the cultures 3) 4) 5) Community-Acquired Pneumonia Roadmap Background Etiology Diagnosis Treatment Prevention 24
25 Roadmap Background Etiology Diagnosis Treatment Prevention 25
26 Etiology of CAP Outpatients (mild) Non-ICU inpatients ICU inpatient Resp. viruses S pneumoniae M pneumoniae C pneumoniae H influenzae Resp. viruses S pneumoniae M pneumoniae C pneumoniae H influenzae Legionella spp S pneumoniae Legionella H influenzae GNRs S aureus Resp. viruses (?) File TM. Lancet 2003;362:1991. Metlay JP, et al. JAMA 1997;278(17):1440. CAP: Current & Future Treatment Principle #1 Outpatients (mild) Resp. viruses S pneumoniae M pneumoniae C pneumoniae H influenzae Must cover all these organisms 26
27 Treatment Principle #2 Outpatients (mild) Resp. viruses S pneumoniae M pneumoniae C pneumoniae H influenzae Wimpy pneumococcus Drug-resistant angry S. pneumoniae (DRSP) Penicillin, erythromycin, macrolides, etc. Risk Factors for DRSP Age > 65 years old Chronic disease Heart, lung, renal, liver Diabetes mellitus Alcoholism Malignancy (active) Immunosuppression Antibiotics in the last 3 months 27
28 Treatment Principle #2 Outpatients (mild) Resp. viruses S pneumoniae M pneumoniae C pneumoniae H influenzae Wimpy pneumococcus Drug-resistant angry S. pneumoniae (DRSP) Penicillin, erythromycin, macrolides, etc. Treatment CAP 28
29 Treatment of CAP Treatment CAP Outpatient, healthy, no DRSP risk factors Doxycycline or macrolide Macrolide = azithro, clarithro, erythro 29
30 Treatment CAP Risk Factors for DRSP Age > 65 years old Chronic disease Heart, lung, renal, liver Diabetes mellitus Alcoholism Malignancy Immunosuppression Antibiotics in the last 3 months 30
31 Treatment CAP Outpatient, DRSP risk factors Oral fluoroquinolone OR Oral β-lactam + doxy OR β-lactam + macrolide (DRSP = drug-resistant angry strep pneumo) NOTE: macrolides are not indicated for outpatients with DRSP risk factors (US resistance > 40%) Treatment CAP Outpatient, DRSP risk factors Oral fluoroquinolone OR Oral β-lactam + doxy OR β-lactam + macrolide Oral fluoroquinolone: moxi, gemi, levofloxacin β-lactam: High-dose amoxicillin (1mg PO tid) Amoxicillin/clavulanate (875mg PO bid) 31
32 Take Home Points 1) Cover typical and atypical bacteria 2) Get the CXR, skip the cultures 3) 4) 5) Community-Acquired Pneumonia Take Home Points 1) Cover typical and atypical bacteria 2) Get the CXR, skip the cultures 3) Outpatient: Brad Pitt vs. Donald Rumsfeld 4) 5) Community-Acquired Pneumonia 32
33 3. A 72 year-old man with a PMH of gout and DJD presents to your clinic with cough and shortness of breath. Based on the history, exam, and CXR (RML infiltrate), he is diagnosed with community-acquired pneumonia. He is well enough to be treated as an outpatient. He has no allergies. Which of the following is the best treatment regimen? A. Levofloxacin PO B. Azithromycin PO C. Ertapenem D. Ampicillin/clavulanate PO and azithromycin PO E. Zosyn & Vanco & Flagyl Risk Factors for DRSP Age > 65 years old Chronic disease Heart, lung, renal, liver Diabetes mellitus Alcoholism Malignancy Immunosuppression Antibiotics in the last 3 months 33
34 Treatment CAP Outpatient, DRSP risk factors Oral fluoroquinolone OR Oral β-lactam + doxy OR β-lactam + macrolide Oral fluoroquinolone: moxi, gemi, levofloxacin β-lactam: High-dose amoxicillin (1mg PO tid) Amoxicillin/clavulanate (875mg PO bid) 3. A 72 year-old man with a PMH of gout and DJD presents to your clinic with cough and shortness of breath. Based on the history, exam, and CXR (RML infiltrate), he is diagnosed with community-acquired pneumonia. He is well enough to be treated as an outpatient. He has no allergies. Which of the following is the best treatment regimen? A. Levofloxacin PO B. Azithromycin PO C. Ertapenem D. Ampicillin/clavulanate PO and azithromycin PO E. Zosyn & Vanco & Flagyl 34
35 4. A healthy 41 year-old woman who was recently treated (1 month ago) for cystitis with cipro presents to your clinic with fever, cough, sob. Her CXR reveals RLL infiltrate and you diagnose community-acquired pneumonia and decide to treat as an outpatient. Which of the following is the best treatment regimen? A. Levofloxacin PO B. Azithromycin PO C. Ertapenem D. Ampicillin/clavulanate PO and azithromycin PO E. Doxycycline PO and penicillin PO Risk Factors for DRSP Age > 65 years old Chronic disease Heart, lung, renal, liver Diabetes mellitus Alcoholism Malignancy Immunosuppression Antibiotics in the last 3 months 35
36 4. A healthy 41 year-old woman who was recently treated (1 month ago) for cystitis with cipro presents to your clinic with fever, cough, sob. Her CXR reveals RLL infiltrate and you diagnose community-acquired pneumonia and decide to treat as an outpatient. Which of the following is the best treatment regimen? A. Levofloxacin PO B. Azithromycin PO C. Ertapenem D. Ampicillin/clavulanate PO and azithromycin PO E. Doxycycline PO and penicillin PO Treatment CAP Outpatient, healthy, no DRSP risk factors Doxycycline or macrolide Outpatient, DRSP risk factors Oral fluoroquinolone OR Oral β-lactam + doxy or β-lactam + macrolide 36
37 Treatment Inpatient CAP Inpatient, non- ICU Fluoroquinolone OR β-lactam + macrolide OR β-lactam + doxycycline** ** At UCSF, we use ceftriaxone & doxycycline Treatment Inpatient CAP Inpatient, non- ICU Inpatient, ICU Fluoroquinolone OR β-lactam + macrolide OR β-lactam + doxycycline** IV β-lactam + macrolide + vancomycin OR IV β-lactam + fluoroquinolone + vancomycin ** At UCSF, we use ceftriaxone & doxycycline 37
38 Treatment CAP: New Data Treatment CAP: New Data Two European RCTs comparing β-lactam alone to either β-lactam + macrolide OR to a fluoroquinolone One study showed no difference One study showed better outcomes with atypical coverage for: 1) Sicker patients 2) Atypical pathogens 38
39 Treatment CAP: New Data May not be generalizable: European patient population Used amoxicillin or 2 nd -generation ceph. More than 30% got antibiotics before admission Not enough to change practice Duration of therapy 39
40 4. A 67 year-old man with CHF and diabetes is admitted to the hospital with CAP (non-icu). He is treated with ceftriaxone and doxycycline and does well. The cultures are all negative. On hospital day 3 he is ready for discharge. What is the optimal duration of total therapy for his CAP? A. 14 days B. 10 days C. 7 days D. 3 days E. Who cares. He probably won t take it anyway. I hate my job. Duration of therapy? Meta-analysis of 15 RCTs, 2796 patients with mild to moderate CAP Compared short-course (< 7 days) with longer courses. Looked at clinical failure, bacterial eradication, and mortality. Li JZ, et al. Am J Med. 2007;120:
41 Duration of therapy? No difference in clinical failure No difference in bacterial eradication No difference in mortality In subgroup analysis, trend toward favorable efficacy with short-course. Li JZ, et al. Am J Med. 2007;120:783. Duration of therapy Patients with CAP should be treated for a minimum of 5 days (level I evidence) -- IDSA/ATS Guidelines 41
42 Duration of therapy Minimum of 5 days If afebrile for For most, 7 days total 4. A 67 year-old man with CHF and diabetes is admitted to the hospital with CAP (non-icu). He is treated with ceftriaxone and doxycycline and does well. The cultures are all negative. On hospital day 3 he is ready for discharge. What is the optimal duration of total therapy for his CAP? A. 14 days B. 10 days C. 7 days D. 3 days E. Who cares. He probably won t take it anyway. I hate my job. 42
43 Take Home Points 1) Cover typical and atypical bacteria 2) Get the CXR, skip the cultures 3) Outpatient: Brad Pitt vs. Donald Rumsfeld 4) 5) Community-Acquired Pneumonia Take Home Points 1) Cover typical and atypical bacteria 2) Get the CXR, skip the cultures 3) Outpatient: Brad Pitt vs. Donald Rumsfeld 4) Treat for 7 days (or 5) 5) Community-Acquired Pneumonia 43
44 Steroids in Pneumonia? CAP: Current & Future Follow-up CXR? Standard practice? Prior ATS guidelines said yes, recent guidelines do not address CXR resolution: At 28 days, ~ 50% had not resolved Can consider in high-risk patients Significant smoking history, etc. Probably should wait > 3 months Bruns AH. CID. 2007;45:
45 Roadmap Background Etiology Diagnosis Treatment Prevention Vaccinations In general, follow the national guidelines Pneumococcal and influenza vaccine 45
46 Pneumovax Updated meta-analysis of 18 RCTs (~64,000 pts) and 7 non-rcts (~62,000 pts) Only high-quality studies Relative Risk All-cause pneumonia 0.70 ( ) All-cause mortality 0.90 ( ) ** No difference for elderly or chronic illness Moberly S, et al. Cochrane. 2013; 1:CD CAP: Current & Future Pneumovax - Efficacy Four different trials looking at benefits of pneumovax in patients hospitalized with CAP Compared vaccinated vs. non-vaccinated Looked at impact on ICU admission, inpatient mortality, inpatient complications, and LOS CAP: Current & Future 46
47 Pneumovax - Efficacy Variable ICU admission Inpt complications LOS Inpt mortality Outcome Decreased Decreased Decreased Decreased CAP: Current & Future Pneumovax - Efficacy Pneumococcal vaccine likely prevents invasive pneumococcal disease. Probably reduces death, ICU admission, complications, and LOS in patients hospitalized with CAP ( makes pneumonia less bad ) CAP: Current & Future 47
48 Influenza Vaccine - Efficacy Adults aged < 65 years Prevents influenza illness in ~ 70-90% Adults aged > 65 years Prevents influenza illness in ~ 30-70% ACIP Recs. MMWR 2003;52:1. CAP: Current & Future Influenza Vaccine - Efficacy Hospitalization Risk Reduction Hospitalization for pna/flu 27%* All cause death 48%* * All p values < Nichol KL, et al. N Engl J Med 2007;357:1373. (Oct 4, 2007) CAP: Current & Future 48
49 Roadmap Background Etiology Diagnosis Treatment Prevention Avoid the purple pill! Proton Pump Inhibitors Gulmez, et al. Arch Intern Med Current use of PPI: CAP OR = Recent start: CAP OR = 5.0 Sarkar, et al. Ann Intern Med Recent PPI start: CAP OR = 3.8 Herzig, et al. JAMA % of hosp pts got PPI, HAP OR = 1.3 Eurich, et al. Am J Med Rates recurrent CAP after CAP admit -- Starting PPI: OR 2.1% (7% abs risk) 49
50 Anti-psychotics Knol W, et al. JAGS Recent anti-psychotic start (1 wk); OR 4.3** Trifiro, et al. Ann Intern Med Population based study, 2000 patients. Current Use Risk of pneumonia Typical anti-psychotic OR = 2.6 ( ) Atypical OR = 1.8 ( ) CAP: Current & Future Take Home Points 1) Cover typical and atypical bacteria 2) Get the CXR, skip the cultures 3) Outpatient: Brad Pitt vs. Donald Rumsfeld 4) Treat for 7 days (or 5) 5) Community-Acquired Pneumonia 50
51 Take Home Points 1) Cover typical and atypical bacteria 2) Get the CXR, skip the cultures 3) Outpatient: Brad Pitt vs. Donald Rumsfeld 4) Treat for 7 days (or 5) 5) Vaccines = good Community-Acquired Pneumonia Roadmap Background Etiology Diagnosis Treatment Prevention 51
52 Take Home Points 1) Cover typical and atypical bacteria 2) Get the CXR, skip the cultures 3) Outpatient: Brad Pitt vs. Donald Rumsfeld 4) Treat for 7 days (or 5) 5) Vaccines = good Community-Acquired Pneumonia Community-Acquired Pneumonia Current & Future State Brad Sharpe, M.D. Professor of Clinical Medicine Department of Medicine UCSF sharpeb@medicine.ucsf.edu 52
53 Urine Pneumococcal Antigen Rapid test, specificity > 90% If positive, tx for pneumococcal disease May not reduce antibiotic spectrum -- > 70% with no change Sorde R, et al. Arch Intern Med. 2011;171:
54 Doxycycline Similar spectrum to macrolides Much cheaper! Good side effect profile (GI upset) Less Clostridium difficile infection Rates 27% lower in hospitalized patients with CAP vs. other regimens Doernberg SB, et al. Clin Infect Dis Sep;55:
55 CURB-65 Score Validated severity-of-illness scoring system Retrospective then prospective Advocated by the British Thoracic Society Based on five easily measurable clinical factors Lim WS. Thorax 2003; 58:
56 CURB-65 Score C Confusion (disoriented) U BUN > 20mg/dL R RR > 30/min B SBP < 90mmHg or DBP < 60mmHg 65 Age > 65 Lim WS. Thorax 2003; 58: CURB65 Score CURB65 Score Mortality 0 0.7% 1 2.5% % % % % Lim WS. Thorax 2003; 58:
57 CURB65 Score CURB65 Mortality Treatment 0 0.7% Outpatient 1 2.3% Outpatient % Inpatient % Inpatient % ICU % ICU Lim WS. Thorax 2003; 58: Admission Decision Consider using a prognostic score in CAP Especially useful in borderline cases CURB65 easy to use 57
Pneumonia considerations Galia Rahav Infectious diseases unit Sheba medical center
Pneumonia considerations 2017 Galia Rahav Infectious diseases unit Sheba medical center Sir William Osler (1849 1919) "Father of modern medicine Pneumonia: The old man's friend The captain of the men of
More informationPneumonia. Community Acquired Pneumonia (CAP): definition. At least 2 new symptoms
Pneumonia Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital Community Acquired Pneumonia (CAP): definition At least 2 new symptoms Fever or hypothermia Cough Rigors
More informationCommunity-Acquired Pneumonia. Community-Acquired Pneumonia. Community Acquired Pneumonia (CAP): definition
Community-Acquired Pneumonia Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital Community-Acquired Pneumonia Talk will focus on adults Guideline for healthy infants
More informationGUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes
More informationCommunity Acquired Pneumonia. Epidemiology: Acute Lower Respiratory Tract Infections. Community Acquired Pneumonia (CAP) Outline
Community Acquired Pneumonia (CAP) Outline Lisa G. Winston, MD University of California, San Francisco Zuckerberg San Francisco General Epidemiology Diagnosis Microbiology Risk stratification Treatment
More informationCommunity-Acquired Pneumonia. Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital. Nothing to disclose.
Community-Acquired Pneumonia Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital Nothing to disclose. Community-Acquired Pneumonia Talk will focus on adults Guideline
More informationObjectives 4/26/2017. Co-Investigators Sadie Giuliani, PharmD, BCPS Claude Tonnerre, MD Jayme Hartzell, PharmD, MS, BCPS
IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP) Lucas Schonsberg, PharmD PGY-1 Pharmacy Practice Resident Providence St. Patrick Hospital Missoula,
More informationControl emergence of drug-resistant. Reduce costs
...PRESENTATIONS... Guidelines for the Management of Community-Acquired Pneumonia Richard E. Chaisson, MD Presentation Summary Guidelines for the treatment of community-acquired pneumonia (CAP) have been
More informationIMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP)
IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP) Lucas Schonsberg, PharmD PGY-1 Pharmacy Practice Resident Providence St. Patrick Hospital Missoula,
More informationAppropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases
Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses
More informationCommunity-acquired pneumonia: Time to place a CAP on length of treatment?
LOGIN TO LEARN: An Engaging and Interactive Journal Club for Pharmacists and Students Community-acquired pneumonia: Time to place a CAP on length of treatment? Jennifer Ball, PharmD Learning Objectives
More informationBai-Yi Chen MD. FCCP
Treatment strategies for hospitalized versus nonhospitalized CAP patients: Asian perspective Bai-Yi Chen MD. FCCP Professor of Medicine Division of Infectious Disease, Infection Control Team The First
More informationEvaluating the Role of MRSA Nasal Swabs
Evaluating the Role of MRSA Nasal Swabs Josh Arnold, PharmD PGY1 Pharmacy Resident Pharmacy Grand Rounds February 28, 2017 2016 MFMER slide-1 Objectives Identify the pathophysiology of MRSA nasal colonization
More informationPneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC
Pneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC APPROVED BY: Policy and Guidelines Committee TRUST REFERENCE: B9/2009 AWP Ref: AWP61 Date (approved): July 2008 REVIEW
More information10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally
Low: not well absorbed PO agent not for serious infection nitrofurantoin Good: [blood and tissue] < than if given IV [Therapeutic] in excess of [effective] eg. cephalexin High: > 90% absorption orally
More information10/26/2015. Year in Review Brad Sharpe, MD UCSF Division of Hospital Medicine VS. Update in Hospital Medicine
Year in Review 2015 Brad Sharpe, MD UCSF Division of Hospital Medicine VS. 1 2015 Updated literature Sept 2014 Sept 2015 Process: CME collaborative review of journals Including ACP J. Club, J. Watch, etc.
More informationMeasure Information Form
Release Notes: Measure Information Form Version 3.0b **NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE** Measure Set: Pneumonia (PN) Performance Measure Identifier: Measure Information Form
More informationInfectious Disease Update 2017
Infectious Disease Update 2017 Greg Moran, MD, FACEP, FIDSA Professor of Clinical Emergency Medicine Geffen School of Medicine at UCLA Dept. of Emergency Medicine and Division of Infectious Diseases Olive
More informationGuidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)
Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Community Acquired Community Acquired 1) Is it pneumonia? ie new symptoms and signs of a lower respiratory
More informationAntibiotic usage in nosocomial infections in hospitals. Dr. Birgit Ross Hospital Hygiene University Hospital Essen
Antibiotic usage in nosocomial infections in hospitals Dr. Birgit Ross Hospital Hygiene University Hospital Essen Infection control in healthcare settings - Isolation - Hand Hygiene - Environmental Hygiene
More informationTreatment Duration for Uncomplicated Community-Acquired Pneumonia: The Evidence in Support of 5 Days
Treatment Duration for Uncomplicated Community-Acquired Pneumonia: The Evidence in Support of 5 Days Executive Summary National consensus guidelines created jointly by the Infectious Diseases Society of
More informationAntimicrobial Stewardship in Ambulatory Care
Antimicrobial Stewardship in Ambulatory Care Nila Suntharam, M.D. May 5, 2017 Dr. Suntharam indicated no potential conflict of interest to this presentation. She does not intend to discuss any unapproved/investigative
More informationCLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met:
CLINICAL PROTOCOL F COMMUNITY ACQUIRED PNEUMONIA SCOPE: Western Australia All criteria must be met: Inclusion Criteria Exclusion Criteria CB score equal or above 1. Mild/moderate pneumonia confirmed by
More informationESISTONO LE HCAP? Francesco Blasi. Sezione Medicina Respiratoria Dipartimento Toraco Polmonare e Cardiocircolatorio Università degli Studi di Milano
ESISTONO LE HCAP? Francesco Blasi Sezione Medicina Respiratoria Dipartimento Toraco Polmonare e Cardiocircolatorio Università degli Studi di Milano Community-acquired pneumonia (CAP): Management issues
More informationRational management of community acquired infections
Rational management of community acquired infections Dr Tanu Singhal MD, MSc Consultant Pediatrics and Infectious Disease Kokilaben Dhirubhai Ambani Hospital, Mumbai Why is rational management needed?
More informationUCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients
Background/methods: UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients This guideline establishes evidence-based consensus standards for management
More information$100 $200 $300 $400 $500
Skin is In Runny Noses Got to go! Hear no evil It s in the Lungs $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400 $500 $500 $500 $500 $500 Double Jeopardy
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More informationNewsflash: Hospital Medicine JOHN C. CHRISTENSEN, MD FACP AMERICAN COLLEGE OF PHYSICIANS, UTAH CHAPTER SCIENTIFIC MEETING FEBRUARY 10, 2017
Newsflash: Hospital Medicine JOHN C. CHRISTENSEN, MD FACP AMERICAN COLLEGE OF PHYSICIANS, UTAH CHAPTER SCIENTIFIC MEETING FEBRUARY 10, 2017 Newsflash: Fluoroquinolones Newsflash: Fluoroquinolones Don t
More informationSafety of an Out-Patient Intravenous Antibiotics Programme
Safety of an Out-Patient Intravenous Antibiotics Programme Chan VL, Tang ESK, Leung WS, Wong L, Cheung PS, Chu CM Department of Medicine & Geriatrics United Christian Hospital Outpatient Parental Antimicrobial
More informationValues and Preferences. Pneumonia Update Key Topics to Cover
Pneumonia Update 2016 Management of the Hospitalized Patient October, 2016 Scott A. Flanders, M.D., MHM Professor of Medicine Director, Hospital Medicine Program Associate Chair for Quality and Innovation
More information8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM
Mary Moore, MS CIC MT (ASCP) Infection Prevention Coordinator Great River Medical Center, West Burlington REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM ABOUT
More informationLet me clear my throat: empiric antibiotics in
Let me clear my throat: empiric antibiotics in respiratory tract infections Alexander John Langley, MD MS MPH Goals of this talk Overuse of antibiotics is a major issue, as a result many specialist medical
More informationGuidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)
Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Community Acquired Pneumonia Community Acquired Pneumonia 1) Is it pneumonia? ie new symptoms and signs of
More informationAntibiotics & Common Infections: Stewardship, Effectiveness, Safety & Clinical Pearls. Welcome We will begin shortly.
Antibiotics & Common Infections: Stewardship, Effectiveness, Safety & Clinical Pearls Welcome We will begin shortly. The Canadian Pharmacists Association is pleased to be collaborating with the following
More informationM5 MEQs 2016 Session 3: SOB 18/11/16
M5 MEQs 2016 Session 3: SOB 18/11/16 http://tinyurl.com/hn7qzt3 Question 1 Ms Tan is a 52 year old female with no past medical history. She comes to the emergency department presenting with a fever for
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form
Last Updated: Version 3.2a NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Pneumonia (PN) Performance Measure Identifier: Measure Information Form Organization Set Measure ID#
More informationECHO: Management of URIs. Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018
ECHO: Management of URIs Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018 Infectious causes of URIs change over time Most ARIs are viral
More informationDuration of antibiotic therapy:
Duration of antibiotic therapy: How low can you go? Thomas Holland, MD Hilton Head, SC July 2017 Disclosures Consulting: The Medicines Company, Basilea Pharmaceutica Adjudication committee: Achaogen Grant
More informationWhat is pneumonia? Infection of the lung parenchyma Causative agents include bacteria, viruses, fungi, protozoa.
Pneumonia What is pneumonia? Infection of the lung parenchyma Causative agents include bacteria, viruses, fungi, protozoa www.netmedicine.com/xray/xr.htm Definition acute infectious disease, etiology usually
More informationAntibiotic Updates: Part II
Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationCompliance with antibiotic treatment guidelines in managed care patients with communityacquired pneumonia in ambulatory settings
Compliance with antibiotic treatment guidelines in managed care patients with communityacquired pneumonia in ambulatory settings Jasmanda H. Wu, Ph.D., 1 David H. Howard, Ph.D., 2 John E. McGowan, Jr.,
More information4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES
CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial
More informationOptimizing Antibiotic Stewardship in the ED
Optimizing Antibiotic Stewardship in the ED Michael Pulia, MD MS FAAEM FACEP Director, UW EM Antibiotic Stewardship Research Program Chair, AAEM Antimicrobial Stewardship Task Force @DrMichaelPulia Learning
More informationAntibiotic Abyss. Discussion Points. MRSA Treatment Guidelines
Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California
More informationIDSA GUIDELINES COMMUNITY ACQUIRED PNEUMONIA
page 1 / 5 page 2 / 5 idsa guidelines community acquired pdf IDSA/ATS Guidelines for CAP in Adults CID 2007:44 (Suppl 2) S29 such as blood and sputum cultures. Conversely, these cultures may have a major
More informationPharmacokinetics. Absorption of doxycycline is not significantly affected by milk or food, but coadministration of antacids or mineral supplements
Pharmacokinetics. Absorption of doxycycline is not significantly affected by milk or food, but coadministration of antacids or mineral supplements should be avoided. PDR Drug Summaries are concise point-of-care
More informationCombination vs Monotherapy for Gram Negative Septic Shock
Combination vs Monotherapy for Gram Negative Septic Shock Critical Care Canada Forum November 8, 2018 Michael Klompas MD, MPH, FIDSA, FSHEA Professor, Harvard Medical School Hospital Epidemiologist, Brigham
More informationCommunity-acquired Pneumonia: Test, Target, Treat
Community-acquired Pneumonia: Test, Target, Treat Thomas M File Jr. MD, MSc Chair, Infectious Disease Division Summa Health System, Akron, Ohio; Professor of Internal Medicine, Chair ID Section Northeast
More informationSHC Clinical Pathway: HAP/VAP Flowchart
SHC Clinical Pathway: Hospital-Acquired and Ventilator-Associated Pneumonia SHC Clinical Pathway: HAP/VAP Flowchart v.08-29-2017 Diagnosis Hospitalization (HAP) Pneumonia develops 48 hours following: Endotracheal
More informationHigh Risk Emergency Medicine. Antibiotic Pitfalls
High Risk Emergency Medicine Antibiotic Pitfalls David, MD MS Assistant Professor Department of Emergency Medicine University of California, San Francisco I. Antibiotic Resistance Development of resistance
More informationPrescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children
Prescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children Prescribing Antimicrobials for Common Illnesses When treating common illnesses such as ear infections and strep throat,
More informationDisclosures. Nothing Medically I own FiPhysician LLC, a financial planning and investment company (FiPhysician.com)
"How to work around (with) administration to build an Antimicrobial Stewardship Program AND how to get dumb (oops reluctant) doctors to do the right thing" David Graham, MD Disclosures Nothing Medically
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Voluntary Only
Last Updated: Version 4.4a NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Pneumonia (PN) Performance Measure Identifier: Measure Information Form Collected For: CMS Voluntary
More informationPneumonia. Jodi Grandominico, MD
Pneumonia Jodi Grandominico, MD Assistant Professor of Clinical Medicine Department of Internal Medicine Division of General Medicine and Geriatrics The Ohio State University Wexner Medical Center Pneumonia
More information10/9/2017. Evidence-Based Interventions to Reduce Inappropriate Prescription of Antibiotics. Prescribing for Respiratory Tract Infections
Evidence-Based Interventions to Reduce Inappropriate Prescription of Antibiotics Ann Thomas, MD, MPH Oregon Public Health Division Prescribing for Respiratory Tract Infections Antibiotic use is primary
More informationOutpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Acute Bacterial Rhinosinusitis
Outpatient Antimicrobial Therapy B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy University of California San Francisco Role of Antibacterials in Outpatient Treatment
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
More informationCost high. acceptable. worst. best. acceptable. Cost low
Key words I Effect low worst acceptable Cost high Cost low acceptable best Effect high Fig. 1. Cost-Effectiveness. The best case is low cost and high efficacy. The acceptable cases are low cost and efficacy
More informationCLINICAL USE OF BETA-LACTAMS
CLINICAL USE OF BETA-LACTAMS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu WHY IS INFECTIOUS DISEASE PHARMACOTHERAPY SO CONFUSING? Microbial
More informationManagement of Hospital-acquired Pneumonia
Management of Hospital-acquired Pneumonia Adel Alothman, MB, FRCPC, FACP Asst. Professor, COM, KSAU-HS Head, Infectious Diseases, Department of Medicine King Abdulaziz Medical City Riyadh Saudi Arabia
More informationAntibiotic Updates: Part I
Antibiotic Updates: Part I Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationCommunity-Acquired Pneumonia: A Re-CAP
Community-Acquired Pneumonia: A Re-CAP Meghan Griebel, PharmD Iowa City VA Health Care System Disclosure Meghan Griebel does not have any actual or potential conflicts of interest to disclose. 2 Goal At
More informationPrinciples of Infectious Disease. Dr. Ezra Levy CSUHS PA Program
Principles of Infectious Disease Dr. Ezra Levy CSUHS PA Program I. Microbiology (1) morphology (e.g., cocci, bacilli) (2) growth characteristics (e.g., aerobic vs anaerobic) (3) other qualities (e.g.,
More informationLifting the lid off CAP guidelines
Lifting the lid off CAP guidelines Dr. Andrew M. Morris September 5, 2007 12:00-13:00 web.mac.com/idologist Objectives 1. To review the epidemiology of community-acquired pneumonia (CAP) 2. To explore
More information11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1
Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director
More informationPneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals
ORIGINAL ARTICLE PNEUMONIA Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals Devin M. West 1, Lindsay M. McCauley 2,3, Jeffrey S. Sorensen 2, Al R. Jephson
More informationRational use of antibiotic in upper respiratory tract infection (URI) and community acquired pneumonia รศ.จามร ธ รตก ลพ ศาล 23 พฤษภาคม 2550
Rational use of antibiotic in upper respiratory tract infection (URI) and community acquired pneumonia รศ.จามร ธ รตก ลพ ศาล 23 พฤษภาคม 2550 Sinusitis Upper respiratory tract infections (URI) Common cold
More informationAntimicrobial Update Stewardship in Primary Care. Clare Colligan Antimicrobial Pharmacist NHS Forth Valley
Antimicrobial Update Stewardship in Primary Care Clare Colligan Antimicrobial Pharmacist NHS Forth Valley Setting the Scene! Consequences of Antibiotic Use? Resistance For an individual patient with
More informationAntimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS
Antimicrobial Stewardship in the Long Term Care and Outpatient Settings Carlos Reyes Sacin, MD, AAHIVS Disclosure Speaker and consultant in HIV medicine for Gilead and Jansen Pharmaceuticals Objectives
More informationInteractive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
More informationInfectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles
Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Conflicts of Interest None at this time May be discussing off-label indications KALIN M. CLIFFORD, PHARM.D., BCPS,
More informationResearch & Reviews: Journal of Hospital and Clinical Pharmacy
Research & Reviews: Journal of Hospital and Clinical Pharmacy Empiric Antibiotic Prescribing For Community Acquired Pneumonia and Patient Characteristics Associated with Broad Spectrum Antibiotic Use Mirza
More informationInfection Comments First Line Agents Penicillin Allergy History of multiresistant. line treatment: persist for >7 days they may be
Gastrointestinal Infections Infection Comments First Line Agents Penicillin Allergy History of multiresistant Campylobacter Antibiotics not recommended. Erythromycin 250mg PO 6 Alternative to first N/A
More informationVolume. December Infection. Notes. length of. cases as 90% 1 week. tonsillitis. First Line. sore throat / daily for 5 days. quinsy >4000.
Volume 8; Number 22 LINCOLNSHIRE GUIDELINES FOR THE TREATMENT OF COMMONLYY OCCURRING INFECTIONS IN PRIMARY CARE: WINTER 2014/15 In this issue of the PACE Bulletin we present an update of our Guidelines
More informationCommunity Acquired Pneumonia (CAP)
Community Acquired Pneumonia (CAP) The following guidelines have been developed to aid clinicians in the investigation and management of patients with CAP at the Royal Liverpool University Hospital (RLUH).
More informationAntibiotics in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Antibiotics in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease Sung Kyu Kim, M.D.Young Sam Kim, M.D. Department of Internal Medicine Yonsei University College of Medicine,
More informationOutpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Vicks Vapo Rub for Cold Symptoms
Outpatient Antimicrobial Therapy B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy University of California San Francisco Role of Antibacterials in Outpatient Treatment
More informationOutpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Vicks VapoRub
Outpatient Antimicrobial Therapy B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy University of California San Francisco Role of Antibacterials in Outpatient Treatment
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required
More informationHost, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus
Host, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus Montana ACP Meeting 2018 September 8, 2018 Staci Lee, MD, MEHP Billings
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More informationDoxycycline for strep pneumonia
Doxycycline for strep pneumonia Antibiotic Levofloxacin (Levaquin) 750 mg, 500 mg for the treatment of respiratory, skin, and urinary tract infections, user reviews and ratings. 14-12-1995 John G. Bartlett,
More informationAZITHROMYCIN, DOXYCYCLINE, AND FLUOROQUINOLONES
AZITHROMYCIN, DOXYCYCLINE, AND FLUOROQUINOLONES Update in Medicine and Primary Care Whitney R. Buckel, PharmD, BCPS-AQ ID System Antimicrobial Stewardship Pharmacist Manager OBJECTIVES 1. List three antibiotics
More informationCommunity Acquired Pneumonia: An Update on Guidelines
Community Acquired Pneumonia: An Update on Guidelines Claudia Summa, BScPhm Pharmacy Resident September 12, 2006 Objectives To give a brief description of the pathophysiology of community acquired pneumonia
More informationOptimize Durations of Antimicrobial Therapy
Optimize Durations of Antimicrobial Therapy Evidence & Application Jill Cowper, Pharm.D. Division Infectious Diseases Pharmacist Parallon Supply Chain Solutions Richmond, VA P: 607 221 5101 jill.butterfield@parallon.com
More informationClostridium Difficile Primer: Disease, Risk, & Mitigation
Clostridium Difficile Primer: Disease, Risk, & Mitigation KALVIN YU, M.D. CHIEF INTEGRATION OFFICER, SCPMG/SCAL KAISER PERMANENTE ASSOCIATE PROFESSOR INFECTIOUS DISEASE, COLLEGE OF GLOBAL PUBLIC HEALTH,
More informationOptimizing Antibiotic Treatment of Skin and Soft Tissue Infections
Optimizing Antibiotic Treatment of Skin and Soft Tissue Infections 15th Annual Rocky Mountain Hospital Medicine Symposium November 6, 2017 Tim Jenkins, MD Director, Antibiotic Stewardship Program Denver
More information3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats
Antibiotics --When Less is More Ralph Gonzales, MD, MSPH Associate Dean, Clinical Innovation School of Medicine VP, Clinical Innovation, UCSF Health Most Urgent Threats Serious Threats Multidrug-Resistant
More informationA year in review in community-acquired respiratory tract infections
A year in review in community-acquired respiratory tract infections Paul M. Tulkens, MD, PhD * Cellular and Molecular Pharmacology & Center for Clinical Pharmacy Louvain Drug Research Institute, Catholic
More informationACUTE EXACERBATIONS of COPD (AE-COPD) : The Belgian perspective
ACUTE EXACERBATIONS of COPD (AE-COPD) : The Belgian perspective Antwerpen 8 november 2002 Yvan Valcke MD PhD AZ Maria Middelares Sint-Niklaas ACUTE EXACERBATIONS of COPD (AE-COPD) Treatment of AECB Role
More information10 Golden rules of Antibiotic Stewardship in ICU. Jeroen Schouten, MD PhD intensivist, Nijmegen (Neth) Istanbul, Oct 6th 2017
10 Golden rules of Antibiotic Stewardship in ICU Jeroen Schouten, MD PhD intensivist, Nijmegen (Neth) Istanbul, Oct 6th 2017 10 golden rules of Antibiotic Stewardship in the ICU ID, Pharma & Micro advice
More informationAntibiotic Stewardship in LTC What does this mean?
Antibiotic Stewardship in LTC What does this mean? Kieran Moore FCFP,FRCPC, Diane Lu CCFP KFLA Public Health Disclosure The findings and conclusions represent those of the presenter and may not necessarily
More informationHost. Case Discussion: optimizing Antimicrobial therapy in Real Practice. To optimize antimicrobial use
Case Discussion: optimizing Antimicrobial therapy in Real Practice Sang Usayaporn, B.Pharm Prof. Terapong Tantawichien, M.D. Chulalongkorn University Griffith M, Postelnick M, Scheetz M. Expert Rev Anti
More information11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose
Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More informationSEPTEMBER 2017 DRUG ANTIBIOTICS COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
SEPTEMBER 2017 DRUG ANTIBIOTICS This optimal usage guide is mainly intended f primary care health professionnals. It is provided f infmation purposes only and should not replace the clinician s judgement.
More informationPrepared: August Review: July Common Infections. A Medicines Optimisation Antibiotic Prescribing Guide.
Prepared: August 2013 Review: July 2014 Common Infections. A Medicines Optimisation Antibiotic Prescribing Guide. Contents Page: Page No Why do we want to review antibiotics? 2 What do NICE say? 3 Acute
More informationAdvanced Practice Education Associates. Antibiotics
Advanced Practice Education Associates Antibiotics Overview Difference between Gram Positive(+), Gram Negative(-) organisms Beta lactam ring, allergies Antimicrobial Spectra of Antibiotic Classes 78 Copyright
More information